ABT R&D to Revenue

Abbott Laboratories · R&D to Revenue

ABT logo

ABT R&D to Revenue

Latest reported6.67%
ABT FY R&D/Revenue (0.00% → 6.67%)
High-resolution chart · PNG

ABT r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
6.6662%
6.7294%
6.779%
6.5333%
6.3564%
6.9868%
7.5476%
7.4825%
7.7766%
6.5123%
6.7091%
6.3516%
6.2752%
3.8722%
10.4512%
10.1585%
8.9184%
9.1061%
9.2715%
9.905%
8.1081%
8.6217%
8.808%
8.8313%
9.687%
9.8285%
9.0605%
9.7901%
10.9598%
10.9397%
10.7144%
10.5233%
10.478%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.